99 results
Page 2 of 5
8-K
EX-99.1
c3e0r4
17 Jan 24
Day One Announces Two New Appointments to Board of Directors
8:25am
8-K
EX-99.2
4o3j40 tvrs6acl5h
8 Jan 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
3ibr m5y6fyy8ej7
8 Jan 24
Regulation FD Disclosure
8:30am
8-K
EX-14.1
xrl2m1r8
8 Dec 23
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:05pm
8-K
EX-99.1
r73h2jw dvz8o8
17 Nov 23
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
7:07am
8-K
EX-99.2
7jf94u11 hwk
17 Nov 23
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
7:07am
8-K
EX-99.2
ag07 twptomphlfzy
6 Nov 23
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.1
b1ha9euy
6 Nov 23
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.1
zc08ri7ug5tlgp322cf
30 Oct 23
Regulation FD Disclosure
8:12am
8-K
EX-99.2
wtx0i y3ju1sjul
30 Oct 23
Regulation FD Disclosure
8:12am
8-K
oydbo
30 Oct 23
Regulation FD Disclosure
8:12am
S-3ASR
imom4bdy2ee6nfqvfyz
14 Sep 23
Automatic shelf registration
5:28pm
8-K
wxbgb1t18nlu ezn
11 Sep 23
Regulation FD Disclosure
8:35am
8-K
EX-99.1
3x5j8x6 l2xt
11 Sep 23
Regulation FD Disclosure
8:35am
8-K
EX-99.2
6as kpq5x6d1mwl
11 Sep 23
Regulation FD Disclosure
8:35am
8-K
EX-99.1
54qzp3pnt7swq2
16 Aug 23
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
8:06am
8-K
EX-99.2
c1ex0h0aii5cy8rppcen
16 Aug 23
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
8:06am
8-K
EX-99.1
mn9qiy9su4l9rnd
7 Aug 23
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
4:30pm